Impact of autologous hematopoietic cell transplantation on disease burden quantified by next‐generation sequencing in multiple myeloma treated with quadruplet therapy
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26640
Abstract: The incremental impact of autologous hematopoietic cell transplantation (AHCT) on disease burden with quadruplet induction in newly diagnosed multiple myeloma (NDDM) can be reappraised with the serial assessment of minimal residual disease (MRD). We describe… read more here.
Keywords: disease; ahct; impact; reduction ... See more keywords
Aminated Hydroximoyl Camelthorn Residues as a Novel Adsorbent for Extracting Hg(II) From Contaminated Water: Studies of Isotherm, Kinetics, and Mechanism
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Polymers and the Environment"
DOI: 10.1007/s10924-020-01789-6
Abstract: Camelthorn, a desert plant, has been utilized as an adsorbent material for the extraction of Hg(II) ions from aqueous solution after grafting with acrylonitrile followed by amination with hydroxylamine hydrochloride in basic medium to obtain… read more here.
Keywords: aminated hydroximoyl; adsorption; order; camelthorn ... See more keywords
Impact of Autologous Hematopoetic Stem Cell Transplant (AHCT) on Measurable Residual Disease (MRD) By Next Generation Sequencing (NGS) in the Setting of Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd) Quadruplet Induction.
Sign Up to like & getrecommendations! Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.091
Abstract: Introduction Unprecedented depth of response is obtained with regimens incorporating monoclonal antibodies in the management of newly diagnosed multiple myeloma (NDMM). The incremental benefit of AHCT in this setting is being reconsidered but can be… read more here.
Keywords: ahct; disease; post; dara krd ... See more keywords
The rise of autologous HCT for autoimmune diseases: what is behind it and what does it mean for the future of treatment? An update on behalf of the EBMT Autoimmune Diseases Working Party
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2019.1656526
Abstract: Autoimmune diseases (ADs) are now the fastest growing disease category for autologous hematopoietic cell transplantation (aHCT). Despite the evolution of competing biological and targeted therapies, there are poor prognosis patients in many ADs who respond… read more here.
Keywords: autoimmune; diseases working; ebmt autoimmune; ahct ... See more keywords